vs
EXACT SCIENCES CORP（EXAS）与WillScot Holdings Corp（WSC）财务数据对比。点击上方公司名可切换其他公司
EXACT SCIENCES CORP的季度营收约是WillScot Holdings Corp的1.6倍（$878.4M vs $566.0M），EXACT SCIENCES CORP净利率更高（-9.8% vs -33.1%，领先23.3%），EXACT SCIENCES CORP同比增速更快（23.1% vs -6.1%），WillScot Holdings Corp自由现金流更多（$149.7M vs $120.4M），过去两年EXACT SCIENCES CORP的营收复合增速更高（17.4% vs -1.8%）
Exact Sciences是总部位于美国威斯康星州麦迪逊的分子诊断企业，专注于早期癌症检测领域。公司核心产品覆盖结直肠癌筛查与预防场景，其中Cologuard是全球首个获批的结直肠癌粪便DNA检测产品，同时还提供其他多种癌症的筛查服务及精准肿瘤检测解决方案。
WillScot Holdings Corp是北美领先的模块化空间及便携式存储服务供应商，服务覆盖建筑、商业开发、教育、医疗、政府项目、特殊活动等多个领域，为客户提供灵活可扩展的临时及半永久空间解决方案。
EXAS vs WSC — 直观对比
营收规模更大
EXAS
是对方的1.6倍
$566.0M
营收增速更快
EXAS
高出29.2%
-6.1%
净利率更高
EXAS
高出23.3%
-33.1%
自由现金流更多
WSC
多$29.3M
$120.4M
两年增速更快
EXAS
近两年复合增速
-1.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $878.4M | $566.0M |
| 净利润 | $-86.0M | $-187.3M |
| 毛利率 | 70.1% | 50.4% |
| 营业利润率 | -9.4% | -32.5% |
| 净利率 | -9.8% | -33.1% |
| 营收同比 | 23.1% | -6.1% |
| 净利润同比 | 90.1% | -310.0% |
| 每股收益（稀释后） | $-0.45 | $-1.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXASWSC
| Q4 25 | $878.4M | $566.0M | ||
| Q3 25 | $850.7M | $566.8M | ||
| Q2 25 | $811.1M | $589.1M | ||
| Q1 25 | $706.8M | $559.6M | ||
| Q4 24 | $713.4M | $602.5M | ||
| Q3 24 | $708.7M | $601.4M | ||
| Q2 24 | $699.3M | $604.6M | ||
| Q1 24 | $637.5M | $587.2M |
净利润EXASWSC
| Q4 25 | $-86.0M | $-187.3M | ||
| Q3 25 | $-19.6M | $43.3M | ||
| Q2 25 | $-1.2M | $47.9M | ||
| Q1 25 | $-101.2M | $43.1M | ||
| Q4 24 | $-864.6M | $89.2M | ||
| Q3 24 | $-38.2M | $-70.5M | ||
| Q2 24 | $-15.8M | $-46.9M | ||
| Q1 24 | $-110.2M | $56.2M |
毛利率EXASWSC
| Q4 25 | 70.1% | 50.4% | ||
| Q3 25 | 68.6% | 49.7% | ||
| Q2 25 | 69.3% | 50.3% | ||
| Q1 25 | 70.8% | 53.7% | ||
| Q4 24 | 69.0% | 55.8% | ||
| Q3 24 | 69.4% | 53.5% | ||
| Q2 24 | 69.8% | 54.1% | ||
| Q1 24 | 70.0% | 54.0% |
营业利润率EXASWSC
| Q4 25 | -9.4% | -32.5% | ||
| Q3 25 | -3.0% | 21.0% | ||
| Q2 25 | -0.3% | 21.5% | ||
| Q1 25 | -13.6% | 21.3% | ||
| Q4 24 | -122.8% | 28.9% | ||
| Q3 24 | -5.6% | -5.9% | ||
| Q2 24 | -3.8% | -0.9% | ||
| Q1 24 | -16.7% | 22.1% |
净利率EXASWSC
| Q4 25 | -9.8% | -33.1% | ||
| Q3 25 | -2.3% | 7.6% | ||
| Q2 25 | -0.1% | 8.1% | ||
| Q1 25 | -14.3% | 7.7% | ||
| Q4 24 | -121.2% | 14.8% | ||
| Q3 24 | -5.4% | -11.7% | ||
| Q2 24 | -2.3% | -7.7% | ||
| Q1 24 | -17.3% | 9.6% |
每股收益（稀释后）EXASWSC
| Q4 25 | $-0.45 | $-1.02 | ||
| Q3 25 | $-0.10 | $0.24 | ||
| Q2 25 | $-0.01 | $0.26 | ||
| Q1 25 | $-0.54 | $0.23 | ||
| Q4 24 | $-4.69 | $0.48 | ||
| Q3 24 | $-0.21 | $-0.37 | ||
| Q2 24 | $-0.09 | $-0.25 | ||
| Q1 24 | $-0.60 | $0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $964.7M | $14.6M |
| 总债务越低越好 | — | $3.6B |
| 股东权益账面价值 | $2.4B | $856.3M |
| 总资产 | $5.9B | $5.8B |
| 负债/权益比越低杠杆越低 | — | 4.15× |
8季度趋势，按日历期对齐
现金及短期投资EXASWSC
| Q4 25 | $964.7M | $14.6M | ||
| Q3 25 | $1.0B | $14.8M | ||
| Q2 25 | $858.4M | $12.8M | ||
| Q1 25 | $786.2M | $10.7M | ||
| Q4 24 | $1.0B | $9.0M | ||
| Q3 24 | $1.0B | $11.0M | ||
| Q2 24 | $946.8M | $5.9M | ||
| Q1 24 | $652.1M | $13.1M |
总债务EXASWSC
| Q4 25 | — | $3.6B | ||
| Q3 25 | — | $3.6B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $3.6B | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $3.5B |
股东权益EXASWSC
| Q4 25 | $2.4B | $856.3M | ||
| Q3 25 | $2.5B | $1.1B | ||
| Q2 25 | $2.5B | $1.0B | ||
| Q1 25 | $2.4B | $1.0B | ||
| Q4 24 | $2.4B | $1.0B | ||
| Q3 24 | $3.2B | $1.1B | ||
| Q2 24 | $3.2B | $1.2B | ||
| Q1 24 | $3.1B | $1.3B |
总资产EXASWSC
| Q4 25 | $5.9B | $5.8B | ||
| Q3 25 | $5.9B | $6.1B | ||
| Q2 25 | $5.8B | $6.1B | ||
| Q1 25 | $5.7B | $6.0B | ||
| Q4 24 | $5.9B | $6.0B | ||
| Q3 24 | $6.7B | $6.0B | ||
| Q2 24 | $6.7B | $6.0B | ||
| Q1 24 | $6.4B | $6.2B |
负债/权益比EXASWSC
| Q4 25 | — | 4.15× | ||
| Q3 25 | — | 3.39× | ||
| Q2 25 | — | 3.55× | ||
| Q1 25 | — | 3.56× | ||
| Q4 24 | — | 3.62× | ||
| Q3 24 | — | 3.42× | ||
| Q2 24 | — | 2.88× | ||
| Q1 24 | — | 2.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $151.7M | $158.9M |
| 自由现金流经营现金流 - 资本支出 | $120.4M | $149.7M |
| 自由现金流率自由现金流/营收 | 13.7% | 26.5% |
| 资本支出强度资本支出/营收 | 3.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $356.8M | $737.7M |
8季度趋势，按日历期对齐
经营现金流EXASWSC
| Q4 25 | $151.7M | $158.9M | ||
| Q3 25 | $219.9M | $191.2M | ||
| Q2 25 | $89.0M | $205.3M | ||
| Q1 25 | $30.8M | $206.6M | ||
| Q4 24 | $47.1M | $178.9M | ||
| Q3 24 | $138.7M | $-1.6M | ||
| Q2 24 | $107.1M | $175.6M | ||
| Q1 24 | $-82.3M | $208.7M |
自由现金流EXASWSC
| Q4 25 | $120.4M | $149.7M | ||
| Q3 25 | $190.0M | $186.9M | ||
| Q2 25 | $46.7M | $199.0M | ||
| Q1 25 | $-365.0K | $202.0M | ||
| Q4 24 | $10.7M | $176.6M | ||
| Q3 24 | $112.6M | $-4.9M | ||
| Q2 24 | $71.2M | $169.4M | ||
| Q1 24 | $-120.0M | $202.1M |
自由现金流率EXASWSC
| Q4 25 | 13.7% | 26.5% | ||
| Q3 25 | 22.3% | 33.0% | ||
| Q2 25 | 5.8% | 33.8% | ||
| Q1 25 | -0.1% | 36.1% | ||
| Q4 24 | 1.5% | 29.3% | ||
| Q3 24 | 15.9% | -0.8% | ||
| Q2 24 | 10.2% | 28.0% | ||
| Q1 24 | -18.8% | 34.4% |
资本支出强度EXASWSC
| Q4 25 | 3.6% | 1.6% | ||
| Q3 25 | 3.5% | 0.7% | ||
| Q2 25 | 5.2% | 1.1% | ||
| Q1 25 | 4.4% | 0.8% | ||
| Q4 24 | 5.1% | 0.4% | ||
| Q3 24 | 3.7% | 0.6% | ||
| Q2 24 | 5.1% | 1.0% | ||
| Q1 24 | 5.9% | 1.1% |
现金转化率EXASWSC
| Q4 25 | — | — | ||
| Q3 25 | — | 4.41× | ||
| Q2 25 | — | 4.28× | ||
| Q1 25 | — | 4.80× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXAS
| Screening | $695.1M | 79% |
| Precision Oncology | $183.2M | 21% |
WSC
| Modular Space Leasing | $249.8M | 44% |
| Value Added Product And Services | $101.0M | 18% |
| Portable Storage Leasing | $83.0M | 15% |
| Delivery Revenue | $48.2M | 9% |
| Installation Revenue | $45.0M | 8% |
| Rental Units | $19.7M | 3% |
| New Units | $15.5M | 3% |
| Value Added Services | $10.3M | 2% |
| Other Leasing Related Products And Services | $3.8M | 1% |
